Article Details
Retrieved on: 2021-04-06 19:30:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
ADCs—a type of biopharmaceutical that use a chemical linker to combine monoclonal antibodies with potent cancer meds—are a key technology in ...
Article found on: www.fiercepharma.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here